IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 122 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
  Search
 
   Next article
   Previous article 
   Table of Contents
  
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
   Article in PDF (1,319 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

 
  In this article
   Abstract
   Introduction
   Case Reports
   Discussion
   References
   Article Figures
   Article Tables

 Article Access Statistics
    Viewed5887    
    Printed64    
    Emailed2    
    PDF Downloaded609    
    Comments [Add]    
    Cited by others 32    

Recommend this journal

 


 
CASE REPORT
Year : 2007  |  Volume : 73  |  Issue : 4  |  Page : 253-256

Type I lepra reaction presenting as immune reconstitution inflammatory syndrome


Department of Dermatology, Seth G. S. Medical College and KEM Hospital, Mumbai, India

Correspondence Address:
Vidya Kharkar
OPD 117, Department of Dermatology, Seth G. S. Medical College and KEM Hospital, Parel, Mumbai - 400012
India
Login to access the Email id


DOI: 10.4103/0378-6323.33637

PMID: 17675735

Get Permissions

  Abstract 

Immune reconstitution inflammatory syndrome (IRIS) is an unusual inflammatory reaction due to infectious and non-infectious causes occurring in human Immunodeficiency virus (HIV)-infected patients. IRIS occurs after the initiation of antiretroviral therapy. There are no reports of type I lepra reaction due to IRIS in published literature from India. We report two cases of HIV-infected males who presented with borderline tuberculoid leprosy in type 1 reaction after the initiation of highly active antiretroviral treatment (HAART). Case 1 presented with multiple, tender, erythematous and hypoesthetic plaques on the trunk and extremities after 3 months of antiretroviral therapy. In case 2, type I lepra reaction was observed 2 months after the initiation of HAART.


Keywords: Borderline tuberculoid leprosy, Highly active antiretroviral treatment, Immune reconstitution inflammatory syndrome, Reversal reaction, Type I lepra reaction


How to cite this article:
Kharkar V, Bhor UH, Mahajan S, Khopkar U. Type I lepra reaction presenting as immune reconstitution inflammatory syndrome. Indian J Dermatol Venereol Leprol 2007;73:253-6

How to cite this URL:
Kharkar V, Bhor UH, Mahajan S, Khopkar U. Type I lepra reaction presenting as immune reconstitution inflammatory syndrome. Indian J Dermatol Venereol Leprol [serial online] 2007 [cited 2014 Sep 23];73:253-6. Available from: http://www.ijdvl.com/text.asp?2007/73/4/253/33637



  Introduction Top


Immune reconstitution inflammatory syndrome (IRIS) is a paradoxical deterioration in the clinical status of a human immunodeficiency virus (HIV)-infected patient on highly active antiretroviral treatment (HAART) and is attributed to the treatment-induced recovery of immune system. This immune response can be either against an infectious agent or a non-infectious condition; the former being more common than the latter. [1] Though IRIS obviates the need for secondary prophylaxis in HIV-infected patients, the associated severe inflammation can be responsible for the deterioration in the clinical status of a patient and hence is a double-edged sword. Therefore, it is crucial to recognize this syndrome as successful treatment relies on alleviation of a patient's symptoms without compromising HAART or antimicrobial therapy. With increasing afforbability of HAART, clinicians will put more and more HIV patients on HAART. Hence, an increase in the incidence of IRIS can be expected. We hereby report two cases of leprosy presenting as IRIS in patients receiving HAART.


  Case Reports Top


Case 1

A 35-year-old HIV-infected male patient on HAART (stavudine, lamivudine and nevirapine) since July 2004, presented to us with the complaints of multiple red raised lesions on the trunk and lower extremities of six months duration (3 months after the initiation of HAART). He gave a history of loss of sensations over the lesions and had no history of paraesthesia or motor weakness in his extremities.

Examination revealed multiple, well-defined, erythematous, tender plaques on the chest, lower abdomen, buttock and right calf and a few of these showed satellite lesions [Figure - 1]. The plaque over the buttock showed a superimposed healing ulcer. There was asymmetrical thickening of the right infra-orbital, ulnar, bilateral common peroneal nerves. Sensations over the plaques were decreased. Motor system examination revealed no abnormality.

At the start of therapy, his CD4 counts were 299 cells/mm 3 and 3 months later, they had increased to 504 cells/mm 3 . Viral load was not measured. Biopsy from an erythematous infiltrated plaque showed multiple, elongated tuberculoid granulomas made up of epithelioid cells and lymphocytes. Some of the granulomas showed a caseating center [Figure - 2]. Based on the patient's clinical features and investigations, a diagnosis of borderline tuberculoid leprosy in type 1 upgrading reaction as an IRIS was made. The patient was started on multi-drug therapy for multibacillary leprosy (MDT-MB) with continuation of HAART. However, he did not return for a follow-up visit and could not be traced at his address.

Case 2

A 42-year-old HIV-infected male patient on HAART (stavudine, lamivudine and nevirapine) since February 2006, presented to us with multiple red raised lesions affecting the trunk and lower limbs since six months (two months after the initiation of HAART). There was a gradual increase in the number of the lesions. He experienced pain and tingling over the plaque on the foot.

Examination revealed multiple erythematous plaques with xerotic surface over the right shoulder, right lumbar region, bilateral calves, right thigh and dorsa of the right foot involving middle three toes [Figure - 3]. Touch and pin prick sensations were decreased on the plaques. There was pain on tapping the plaques over the abdomen and foot. There was asymmetrical thickening of right ulnar and radial cutaneous and bilateral common peroneal nerves. Motor examination revealed no abnormality.

Before initiation of HAART, CD4 counts were 114 cells/mm 3 and six months later they had increased slightly to 184 cells/mm 3 . Biopsy from an erythematous infiltrated plaque revealed multiple tuberculoid granulomas mainly in the upper and mid dermis with a few granulomas extending up to the epidermis. Based on these clinical and histopathological findings, a diagnosis of borderline tuberculoid leprosy in type 1 reaction was made. The patient was asked to continue his HAART and was additionally started on MDT-MB. The patient has completed six months of his anti-leprosy medications with improvement in the skin lesions.


  Discussion Top


IRIS is an undesirable inflammatory reaction to a pathogen culminating in the paradoxical deterioration in clinical status due to the recuperating immune system. Initially reported cases of IRIS included reactions to Mycobacterium avium Scientific Name Search  complex infection. [2] Other infections associated with IRIS include viruses (human herpes viruses, hepatitis virus, human papilloma virus ), fungi ( Cryptococcosis neoformans , Histoplasmosis capsulatum ) and protozoa ( Toxoplasma gondii , Pneumocystis jiroveci , Leishmania donovani ). [1] Most of these agents are organisms causing opportunistic infections in HIV patients though non-opportunistic organisms can also elicit such a reaction. However, this paradoxical deterioration is not only seen with infectious conditions but also with sarcoidosis, various autoimmune and neoplastic disorders. [1] The sudden clinical deterioration associated with IRIS can be at times fatal and needs prompt intervention.

Though IRIS is a widely recognized entity now, there is still a lack of universally acceptable diagnostic criteria and consensus of treatment for IRIS. According to Shelburne et al. , a diagnosis of IRIS is warranted in any HIV patient who is on HAART and develops an inflammatory reaction along with a fall in viral load and rise in CD4 cell counts. In addition, the clinical course of this reaction should not be consistent with the usual course of a previously or newly detected opportunistic infection or adverse drug reaction. IRIS most commonly occurs in patients with low CD4 counts (< 200 cells/mm 3 ). Even a minimal decrease in viral load in the absence of a significant rise in CD4 cell count can precipitate IRIS. [3] Treatment of IRIS includes the use of anti-inflammatory drugs, steroids, and specific antimicrobial agents with the continuation of HAART. [1]

IRIS is not a condition specific to HIV-positive patients but can also occur in HIV-negative individuals. In fact, it has been observed for many years notably after the recovery of neutrophil counts from chemotherapy, engraftment after bone marrow transplantation and interruption of long-term immunosuppressive therapy.

Till date, there are only four reports of leprosy presenting as IRIS [Table - 1]. [4],[5],[6],[7] The first case of leprosy diagnosed after the initiation of HAART was reported in 2003 by Lawn et al. [5] In all of them including our two cases, the disease has occurred within 3 months of initiation of HAART. In 2004, the first of the two cases reported by Pignataro et al. [8] was diagnosed after 4 months of starting HAART. However, the clinical history and details provided by the authors suggests that the patient had developed the leprosy lesion as early as 2 months of starting HAART but the diagnosis was not proved. [8] The mean CD4 cell counts before and after starting HAART were 95 cells/mm 3 (range, 72-99 cells/mm 3 ) and 250.3 cells/mm 3 (range, 70-504 cells/mm 3 ) respectively. The baseline CD4 counts were highest in our series of patients which suggests that, IRIS can also occur at higher basal CD4 cell counts. As in our cases, viral load has not been consistently measured by other authors and hence it is difficult to correlate the phenomenon of leprosy manifested as IRIS with viral load and its changing trends.

All of the reported cases including ours (except 2 cases reported by Pignataro et al. , [8] ) belong to the tuberculoid spectrum of leprosy implying that there is a good host immune response. The co-existing type I lepra reaction in all these cases further supports the fact that there is recovery of the immunological system which is the cause for this paradoxical response.

The clinical as well as the patho-mechanisms of leprosy presenting as IRIS and leprosy presenting as type I reaction are different [Table - 2].

In IRIS, the primary event is restoration of immunity by HAART which then recognizes and mounts an immune response against the bacilli. In contrast, in leprosy presenting as type I reaction, initially, there is lysis of bacilli by multi-drug therapy which then restores the immune system and this reconstituted immune response leads to type I reaction.

There is no consensus regarding management of IRIS and hence, leprosy presenting as IRIS has to be managed tactfully with the guidance of some proposed recommendations. [1],[3]

In any HIV-infected patient on HAART who develops tender erythematous plaques or sudden paralysis, leprosy should be ruled out on priority basis especially in endemic areas. It is to be remembered that such reactions are more common in patients with low CD4 counts and during the initial 3 months of initiation of HAART, although variations in the latter are possible.

 
  References Top

1.Stoll M, Schmidt RE. Adverse events of desirable gain in immunocompetence: The Immune Restoration Inflammatory Syndromes. Autoimmun Rev 2004;3:243-9.  Back to cited text no. 1  [PUBMED]  [FULLTEXT]  
2.Shelburne SA, Montes M, Hamill RJ. Immune reconstitution inflammatory syndrome: More answers, more questions. J Antimicrob Chemother 2006;57:167-70.  Back to cited text no. 2  [PUBMED]  [FULLTEXT]  
3.Hirsch HH, Kaufmann G, Sendi P, Battegay M. Immune reconstitution in HIV-infected patients. Clin Infect Dis 2004;38:1159-66.  Back to cited text no. 3  [PUBMED]  [FULLTEXT]  
4.Stone SF, Price P, Brochier J, French MA. Plasma bioavailable interleukin-6 is elevated in human immunodeficiency virus-infected patients who experience herpesvirus-associated immune restoration disease after start of highly active antiretroviral therapy. J Infect Dis 2001;184:1073-7.  Back to cited text no. 4  [PUBMED]  [FULLTEXT]  
5.Lawn SD, Wood C, Lockwood DN. Borderline tuberculoid leprosy: An immune reconstitution phenomenon in a human immunodeficiency virus infected person. Clin Infect Dis 2003;36:e5-6.  Back to cited text no. 5  [PUBMED]  [FULLTEXT]  
6.Couppie P, Abel S, Voinchet H, Roussel M, Helenon R, Huerre M, et al. Immune reconstitution inflammatory syndrome associated with HIV and leprosy. Arch Dermatol 2004;140:997-1000.  Back to cited text no. 6      
7.Visco-Comandini U, Longo B, Cuzzi T, Paglia MG, Antonucci G. Tuberculoid leprosy in a patient with AIDS: A manifestation of immune restoration syndrome. Scand J Infect Dis 2004;36:881-3.  Back to cited text no. 7  [PUBMED]  [FULLTEXT]  
8.Pignataro P, Rocha Ada S, Nery JA, Miranda A, Sales AM, Ferreria H, et al. leprosy and AIDS: Two cases of increasing inflammatory reactions at the start of highly active antiretroviral therapy. Eur J Clin Microbiol Infect Dis 2004;23:408-11.  Back to cited text no. 8      


    Figures

  [Figure - 1], [Figure - 2], [Figure - 3]
 
 
    Tables

  [Table - 1], [Table - 2]

This article has been cited by
1 Immune reconstitution inflammatory syndrome : incidence and implications for mortality
Richard M. Novak, James T. Richardson, Kate Buchacz, Joan S. Chmiel, Marcus D. Durham, Frank J. Palella, Andrea Wendrow, Kathy Wood, Benjamin Young, John T. Brooks
AIDS. 2012; 26(6): 721
[VIEW]
2 Neuropathies au cours de la lèpre
J. Grimaud
Revue Neurologique. 2012; 168(12): 967
[Pubmed]
3 Immune Reconstitution Inflammatory Syndrome and Tropical Dermatoses
Erin Huiras Amerson,Toby A. Maurer
Dermatologic Clinics. 2011; 29(1): 39
[Pubmed]
4 Evaluation of cellular phenotypes implicated in immunopathogenesis and monitoring immune reconstitution inflammatory syndrome in HIV/leprosy cases
# Giacoia-Gripp, C.B.W., Sales, A.M., da Costa Nery, J.A., Santos-Oliveira, J.R., de Oliveira, A.L., Sarno, E.N., Morgado, M.G.
PLoS ONE. 2011; 6(12): art-e28735
[Pubmed]
5 Type 2 lepra reaction with HIV1 co-infection: A case report with interesting management implications
Sachdeva, S., Amin, S.S., Qaisar, S.
Indian Journal of Leprosy. 2011; 83(2): 103-106
[Pubmed]
6 Immune reconstitution inflammatory syndrome in leprosy
Sanghi, S., Grewal, R.S., Vasudevan, B., Lodha, N.
Indian Journal of Leprosy. 2011; 83(2): 61-70
[Pubmed]
7 Leprosy and HIV coinfection: a critical approach
Cesare Massone, Carolina Talhari, Rodrigo Ribeiro-Rodrigues, Renata Helena Monteiro Sindeaux, Marcelo Távora Mira, Sinesio Talhari, Bernard Naafs
Expert Review of Anti-infective Therapy. 2011; 9(6): 701
[VIEW]
8 Immune reconstitution inflammatory syndrome and tropical dermatoses
Amerson, E.H., Maurer, T.A.
Dermatologic Clinics. 2011; 29(1): 39-43
[Pubmed]
9 Histoid leprosy in an HIV positive patient taking cART
Bumb, R.A., Ghiya, B.C., Jakhar, R., Prasad, N.
Leprosy Review. 2010; 81(3): 221-223
[Pubmed]
10 Leprosy and HIV coinfection: A clinical, pathological, immunological, and therapeutic study of a cohort from a brazilian referral center for infectious diseases
Talhari, C., Távora Mira, M., Massone, C., Braga, A., Chrusciak-Talhari, A., Santos, M., Orsi, A.T., (...), Talhari, S.
Journal of Infectious Diseases. 2010; 202(3): 345-354
[Pubmed]
11 Severe peripheral neuropathy following HAART initiation in an HIV-infected patient with leprosy
Pavie, J., De Castro, N., Molina, J.-M., Flageul, B.
Journal of the International Association of Physicians in AIDS Care. 2010; 9(4): 232-235
[Pubmed]
12 Leprosy presenting as immune reconstitution inflammatory syndrome: Proposed definitions and classification
Deps, P., Lockwood, D.N.J.
Leprosy Review. 2010; 81(1): 59-68
[Pubmed]
13 Leprosy and HIV/aids co-infection
Talhari, S.
Nederlands Tijdschrift voor Dermatologie en Venereologie. 2010; 20(10): 626-630
[Pubmed]
14 Dermatopathological challenges in the human immunodeficiency virus and acquired immunodeficiency syndrome era
Pratistadevi K Ramdial
Histopathology. 2010; 56(1): 39-56
[Pubmed]
15 Neurological complications of immune reconstitution in HIV-infected populations
Tory Johnson, Avindra Nath
Annals of the New York Academy of Sciences. 2010; 1184(1): 106
[VIEW]
16 Immunohistochemical study of Langerhans cells in cutaneous lesions of the Jorge Loboæs disease
Quaresma, J.A.S., Unger, D., Pagliari, C., Sotto, M.N., Duarte, M.I.S., de Brito, A.C.
Acta Tropica. 2010; 114(1): 59-62
[Pubmed]
17 Immunohistochemical study of Langerhans cells in cutaneous lesions of the Jorge Loboæs disease
Juarez Antonio Simoes Quaresma,Debora Unger,Carla Pagliari,Mirian Nacagami Sotto,Maria Irma Seixas Duarte,Arival Cardoso de Brito
Acta Tropica. 2010; 114(1): 59
[Pubmed]
18 Leprosy and Kaposi sarcoma presenting as an immune reconstitution inflammatory syndrome in a patient with AIDS
Medeiros, S., Coelho, R., Fernandes, C., Catarino, M.C., Afonso, A., Vieira, R., Rodrigues, A., Cardoso, J.
Journal of the American Academy of Dermatology. 2009; 61(3): 516-518
[Pubmed]
19 Immune reconstitution inflammatory syndrome in children
Rabie, H., Meyers, T., Cotton, M.F.
Southern African Journal of HIV Medicine. 2009; (36): 70-75
[Pubmed]
20 Leprosy and Kaposi sarcoma presenting as an immune reconstitution inflammatory syndrome in a patient with AIDS
Sandra Medeiros,Ricardo Coelho,Cândida Fernandes,Maria Carmo Catarino,Ana Afonso,Raquel Vieira,Ana Rodrigues,Jorge Cardoso
Journal of the American Academy of Dermatology. 2009; 61(3): 516
[Pubmed]
21 Leprosy reaction as a manifestation of immune reconstitution inflammatory syndrome: a case series of a Brazilian cohort
Vinicius Martins Menezes,Anna Maria Sales,Ximena Illarramendi,Alice Miranda,Mariza Gonçalves Morgado,Maria Clara Gutierrez-Galhardo,Euzenir Nunes Sarno,José Augusto da Costa Nery
AIDS. 2009; 23(5): 641
[Pubmed]
22 Leprosy reaction as a manifestation of immune reconstitution inflammatory syndrome: A case series of a Brazilian cohort
Menezes, V.M., Sales, A.M., Illarramendi, X., Miranda, A., Morgado, M.G., Galhardo, M.C.G.-., Sarno, E.N., Nery, J.A.D.C.
AIDS. 2009; 23(5): 641-643
[Pubmed]
23 Leprosy occurring as immune reconstitution syndrome
Deps, P.D., Lockwood, D.N.J.
Transactions of the Royal Society of Tropical Medicine and Hygiene. 2008; 102(10): 966-968
[Pubmed]
24 Leprosy reversal reaction as immune reconstitution inflammatory syndrome in patients with AIDS
Batista, M.D., Porro, A.M., Maeda, S.M., Gomes, E.E., Yoshioka, M.C.N., Enokihara, M.M.S.S., Tomimori, J.
Clinical Infectious Diseases. 2008; 46(6): e56-e60
[Pubmed]
25 Leprosy Reversal Reaction as Immune Reconstitution Inflammatory Syndrome in Patients with AIDS
M. D. Batista,A. M. Porro,S. M. Maeda,E. E. Gomes,M. C. N. Yoshioka,M. M. S. S. Enokihara,J. Tomimori
Clinical Infectious Diseases. 2008; 46(6): e56
[Pubmed]
26 Cutaneous manifestations of immune reconstitution inflammatory syndrome
Erin Huiras,Veronica Preda,Toby Maurer,Margot Whitfeld
Current Opinion in HIV and AIDS. 2008; 3(4): 453
[Pubmed]
27 Immune reconstitution disease associated with mycobacterial infections
Stephen D Lawn,Marc C Lipman,Philippa J Easterbrook
Current Opinion in HIV and AIDS. 2008; 3(4): 425
[Pubmed]
28 Leprosy occurring as immune reconstitution syndrome
Patricia D. Deps,Diana N.J. Lockwood
Transactions of the Royal Society of Tropical Medicine and Hygiene. 2008; 102(10): 966
[Pubmed]
29 Type 1 lepra reaction presenting as immune reconstitution inflammatory syndrome.
Rapose, A.
Indian J Dermatol Venereol Leprol. 2008; 74(3): 265-266
[Pubmed]
30 Immune reconstitution disease associated with mycobacterial infections.
Lawn, S.D. and Lipman, M.C. and Easterbrook, P.J.
Current Opinion in HIV \& AIDS. 2008; 3(4): 425-431
[Pubmed]
31 Latest Articles
Profile, M. and In, L.
Clinical Infectious Diseases. 2008; 46: 000-000
[Pubmed]
32 Cutaneous manifestations of immune reconstitution inflammatory syndrome.
Huiras, E. and Preda, V. and Maurer, T. and Whitfeld, M.
Current Opinion in HIV \& AIDS. 2008; 3(4): 453-460
[Pubmed]



 

Top
Print this article  Email this article
Previous article Next article

    

Online since 15th March '04
Published by Medknow